29th week of 2019 patent applcation highlights part 9 |
Patent application number | Title | Published |
20190216805 | Pharmaceutical Compositions Comprising Sorbitan Esters | 2019-07-18 |
20190216806 | NOVEL USES | 2019-07-18 |
20190216807 | COMBINATIONS OF A PYRIMIDINE CONTAINING NNRTI WITH RT INHIBITORS | 2019-07-18 |
20190216808 | HEPATITIS B ANTIVIRAL AGENTS | 2019-07-18 |
20190216809 | TREATMENT OF CANCER | 2019-07-18 |
20190216810 | SMALL MOLECULE REGULATORS OF STEROID RECEPTOR COACTIVATORS AND METHODS OF USE THEREOF | 2019-07-18 |
20190216811 | Inhibitors of Multidrug Resistance Transporter P-Glycoprotein | 2019-07-18 |
20190216812 | THERAPEUTIC COMPOUNDS AND USES THEREOF | 2019-07-18 |
20190216813 | SUBSTITUTED IMIDAZO[1,5-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS | 2019-07-18 |
20190216814 | LIQUID FORMULATIONS OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRI- MIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE | 2019-07-18 |
20190216815 | COMBINATION THERAPY COMPRISING A POLYUNSATURATED KETONE AND A FOLIC ACID PARTNER | 2019-07-18 |
20190216816 | COMBINATION THERAPIES | 2019-07-18 |
20190216817 | APPLICATION OF METHYL 4-[9-(6-AMINOPURYL)]-2(S)-HYDROXYBUTYRATE IN PREPARATION OF MEDICAMENT FOR TREATING PSORIASIS AND VITILIGO | 2019-07-18 |
20190216818 | HISTONE DEACETYLASE INHIBITORS FOR USE IN IMMUNOTHERAPY | 2019-07-18 |
20190216819 | METHOD OF SYNTHESISING ADCS USING AFFINITY RESINS | 2019-07-18 |
20190216820 | ANTIFUNGAL COMPOSITION | 2019-07-18 |
20190216821 | Chromium Containing Compositions for Improving Health and Fitness | 2019-07-18 |
20190216822 | TREATMENT OF SKIN ATROPHY WITH COMBINATION OF TRIIODOTHYROACETIC ACID (TRIAC) AND DEHYDROEPIANDROSTERONE (DHEA) | 2019-07-18 |
20190216823 | METHYLPREDNISOLONE PHARMACEUTICAL SUSPENSION | 2019-07-18 |
20190216824 | Particles, Compositions and Methods for Ophthalmic and/or Other Applications | 2019-07-18 |
20190216825 | EXTENDED-RELEASE DRUG DELIVERY COMPOSITIONS | 2019-07-18 |
20190216826 | ORAL PREPARATION HAVING EXCEPTIONAL ELUTABILITY | 2019-07-18 |
20190216827 | Composite Formulation of Dutasteride and Tadalafil Comprising Glycerol Fatty Acid Ester Derivative or Propylene Glycol Fatty Acid Ester Derivative and Oral Capsule Formulation Comprising the Same | 2019-07-18 |
20190216828 | Composition for Inhalation | 2019-07-18 |
20190216829 | Anticancer Compositions | 2019-07-18 |
20190216830 | OPHTHALMIC COMPOSITIONS | 2019-07-18 |
20190216831 | ANTIVIRAL COMPOSITION | 2019-07-18 |
20190216832 | NERIDRONIC ACID AND OTHER BISPHOSPHONATES FOR TREATING COMPLEX REGIONAL PAIN SYNDROME AND OTHER DISEASES | 2019-07-18 |
20190216833 | NERIDRONIC ACID AND OTHER BISPHOSPHONATES FOR TREATING COMPLEX REGIONAL PAIN SYNDROME AND OTHER DISEASES | 2019-07-18 |
20190216834 | METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS | 2019-07-18 |
20190216835 | Inhibition of Zika Virus Infection | 2019-07-18 |
20190216836 | INJECTABLE ANTIBIOTIC FORMULATIONS AND USE THEREOF | 2019-07-18 |
20190216837 | COMBINATIONS TO TREAT CANCER | 2019-07-18 |
20190216838 | METHOD OF TREATING LEUKEMIA | 2019-07-18 |
20190216839 | PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING CANCER | 2019-07-18 |
20190216840 | NOVEL USE OF KIRREL2 AND KIRREL2 INHIBITOR | 2019-07-18 |
20190216841 | Regimens and Compositions for AAV-Mediated Passive Immunization of Airborne Pathogens | 2019-07-18 |
20190216842 | VITAMIN B12 NASAL SPRAY AND METHOD OF USE | 2019-07-18 |
20190216843 | Synergistic Enhancement of the Delivery of Nucleic Acids via Blended Formulations | 2019-07-18 |
20190216844 | METHODS TO STABILIZE AND REVERSE ATHEROSCLEROTIC LESIONS BY SULFATED POLYSACCHARIDES | 2019-07-18 |
20190216845 | PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 2019-07-18 |
20190216846 | NUCLEIC ACID MOLECULES FOR REDUCTION OF PAPD5 OR PAPD7 MRNA FOR TREATING HEPATITIS B INFECTION | 2019-07-18 |
20190216847 | Biodegradable, Antioxidant, Thermally Responsive Injectable Hydrogel and Uses Therefor | 2019-07-18 |
20190216848 | New Use of Product for Skin Treatment | 2019-07-18 |
20190216849 | COMPOSITIONS AND METHODS FOR TREATING DISEASE | 2019-07-18 |
20190216850 | ORAL PYROPHOSPHATE FOR USE IN REDUCING TISSUE CALCIFICATION | 2019-07-18 |
20190216851 | Modified Cell Expansion and Uses Thereof | 2019-07-18 |
20190216852 | METHODS OF ASSESSING POTENCY OF VIRAL VECTORS | 2019-07-18 |
20190216853 | USE OF PRE T ALPHA OR FUNCTIONAL VARIANT THEREOF FOR EXPANDING TCR ALPHA DEFICIENT T CELLS | 2019-07-18 |
20190216854 | USE OF PRE T ALPHA OR FUNCTIONAL VARIANT THEREOF FOR EXPANDING TCR ALPHA DEFICIENT T CELLS | 2019-07-18 |
20190216855 | METHOD OF TARGETING ONCOLYTIC VIRUSES TO TUMORS | 2019-07-18 |
20190216856 | CELL PREPARATION AND METHOD FOR PRODUCING CELL PREPARATION | 2019-07-18 |
20190216857 | DELIVERY OF NUCLEIC ACIDS, PROTEINS AND SMALL MOLECULES IN VITREOUS VESICULAR BODIES | 2019-07-18 |
20190216858 | COMPOSITION COMPRISING MYOBLASTS FOR TUMOR GROWTH INHIBITION AND PREVENTION OF CANCER CELL METASTASIS BY IMPLANTATION | 2019-07-18 |
20190216859 | SYSTEMS FOR CHARACTERIZATION OF THE CONTENTS OF THE LARGE INTESTINE AND TREATMENT OF CONDITIONS OF THE LARGE INTESTINE | 2019-07-18 |
20190216860 | Compositions for Fecal Floral Transplantation and Methods for Making and Using Them and Devices for Delivering Them | 2019-07-18 |
20190216861 | METHODS AND MATERIALS FOR USING BIOMARKERS WHICH PREDICT SUSCEPTIBILITY TO CLOSTRIDIUM DIFFICILE INFECTION | 2019-07-18 |
20190216862 | COMPOSITIONS AND METHODS FOR TREATING DISEASE USING A BLAUTIA STRAIN | 2019-07-18 |
20190216863 | METHODS OF REDUCING INCIDENCE OF MORTALITY IN FOWL | 2019-07-18 |
20190216864 | PROBIOTIC BACTERIAL STRAINS AND SYMBIOTIC COMPOSITION CONTAINING THE SAME INTENDED FOR INFANT FOOD | 2019-07-18 |
20190216865 | LACTIC ACID BACTERIAL STRAINS | 2019-07-18 |
20190216866 | COMPOSITE PROBIOTIC LACTIC ACID BACTERIA POWDER AND PREPARATION METHOD AND USE THEREOF | 2019-07-18 |
20190216867 | LACTOBACILLUS SALIVARIUS CJLS1511, ANIMAL FEED ADDITIVE COMPOSITION COMPRISING SAME BACTERIUM OR DEAD CELLS THEREOF, AND METHOD FOR PRODUCING SAME DEAD CELLS | 2019-07-18 |
20190216868 | ONCOLYTIC RHABDOVIRUS EXPRESSING IL12 | 2019-07-18 |
20190216869 | ENCAPSULATED CANNABINOID FORMULATIONS FOR ORAL DELIVERY | 2019-07-18 |
20190216870 | ENCAPSULATED CANNABINOID FORMULATIONS FOR TRANSDERMAL DELIVERY | 2019-07-18 |
20190216871 | DIABETIC FOOT CREAM | 2019-07-18 |
20190216872 | COMPOSITIONS FOR ENHANCING BRAIN ACTIVITY | 2019-07-18 |
20190216874 | COMMON BEAN (PHASEOLUS VULGARIS) EXTRACT WITH HIGH a-AMYLASE INHIBITORY ACTIVITY AND LOW HEMAGGLUTININ ACTIVITY | 2019-07-18 |
20190216875 | POLYPHENOL COMPOSITION AND METHOD OF ITS USE AND MANUFACTURE IN THE TREATMENT OF METABOLIC DISORDERS | 2019-07-18 |
20190216876 | METHOD FOR PROCESSING RAW SUGARCANE MAXIMIZING THE PRESERVATION OF POLICOSANOLS DURING PRODUCTION OF A NATURAL SUGARCANE JUICE-BASED PRODUCT | 2019-07-18 |
20190216877 | COMPOSITION COMPRISING POLLEN AND/OR PISTIL EXTRACTS, PREPARATION PROCESS AND ASSOCIATED USES | 2019-07-18 |
20190216878 | COMPOSITIONS FOR TREATING AND PREVENTING LAMINITIS, FOUNDER AND OVEREATING IN AN UNGULATE | 2019-07-18 |
20190216879 | PROTEIN INTERFACES | 2019-07-18 |
20190216880 | COMPOSITION FOR TOPICAL USE BASED ON A CARNOSINE-MAGNESIUM COMPLEX | 2019-07-18 |
20190216881 | METHODS AND COMPOSITIONS FOR PRESERVING PHOTORECEPTOR AND RETINAL PIGMENT EPITHELIAL CELLS | 2019-07-18 |
20190216882 | Solid Pharmaceutical Compositions for Treating HCV | 2019-07-18 |
20190216883 | USE OF PEPTIDE COMPOUNDS IN TREATING ACUTE PANCREATITIS | 2019-07-18 |
20190216884 | EXTRACELLULAR HISTONES AS BIOMARKERS FOR PROGNOSIS AND MOLECULAR TARGETS FOR THERAPY | 2019-07-18 |
20190216885 | DOSING REGIMENS FOR TREATMENT OF FUNGAL INFECTIONS | 2019-07-18 |
20190216886 | Topical Compositions And Methods For Treating Wounds | 2019-07-18 |
20190216887 | Melanocortin Receptor-Specific Peptides | 2019-07-18 |
20190216889 | METHODS AND COMPOSITIONS FOR TREATMENT OF FIBROSIS | 2019-07-18 |
20190216890 | COMPOSITIONS, METHODS AND USES COMPRISING TENEURIN C-TERMINAL ASSOCIATED PEPTIDE -1 (TCAP-1) FOR ENHANCING MUSCLE PERFORMANCE | 2019-07-18 |
20190216891 | METHOD FOR MODULATING MYELINATION | 2019-07-18 |
20190216892 | HISTONE DEACETYLASE (HDAC) INHIBITOR UP-REGULATES CAR EXPRESSION AND TARGETED ANTIGEN INTENSITY, INCREASING ANTITUMOR EFFICACY | 2019-07-18 |
20190216893 | COMPOSITIONS AND METHODS OF MODULATING IMMUNE RESPONSE | 2019-07-18 |
20190216894 | Medical Use of Creg Protein for Prevention or Treatment of Overweight, Obesity and Related Diseases Thereof | 2019-07-18 |
20190216895 | BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF | 2019-07-18 |
20190216896 | Embryo Implantation | 2019-07-18 |
20190216897 | DETECTION OF CD5 AND METHODS AND COMPOSITIONS FOR MODULATING CD5 | 2019-07-18 |
20190216898 | Interleukin Combination and Use Thereof | 2019-07-18 |
20190216899 | SYSTEMS AND METHODS FOR CARDIAC PLEXUS NEUROMODULATION | 2019-07-18 |
20190216900 | METHODS OF TREATING MILD BRAIN INJURY | 2019-07-18 |
20190216901 | ACTH PROPHYLACTIC TREATMENT OF RENAL DISORDERS | 2019-07-18 |
20190216902 | AMINO ACID COMPOSITION FOR COLLAGEN FORMATION | 2019-07-18 |
20190216903 | METHODS OF CYTOTOXIC GENE THERAPY TO TREAT TUMORS | 2019-07-18 |
20190216904 | METHODS AND PHARMACEUTICALS FOR TREATMENT OF VIRAL INFECTIONS OF THE EYE | 2019-07-18 |
20190216905 | TPP-1 Formulations and Methods for Treating CLN2 Disease | 2019-07-18 |
20190216906 | POLYVALENT VENOM VACCINES, METHODS OF USE AND MAKING | 2019-07-18 |